Social Europe

politics, economy and employment & labour

  • Projects
    • Corporate Taxation in a Globalised Era
    • US Election 2020
    • The Transformation of Work
    • The Coronavirus Crisis and the Welfare State
    • Just Transition
    • Artificial intelligence, work and society
    • What is inequality?
    • Europe 2025
    • The Crisis Of Globalisation
  • Audiovisual
    • Audio Podcast
    • Video Podcasts
    • Social Europe Talk Videos
  • Publications
    • Books
    • Dossiers
    • Occasional Papers
    • Research Essays
    • Brexit Paper Series
  • Shop
  • Membership
  • Ads
  • Newsletter

Challenging patents key to make Covid-19 vaccine work for all

by Kateřina Konečná on 2nd July 2020 @Konecna_K

Share on TwitterShare on FacebookShare on LinkedIn

Finding a vaccine against the coronavirus is a biochemical challenge. Ensuring universal access to it, however, is a political choice.

Covid-19 vaccine, pharamaceutical companies, patents
Kateřina Konečná

Since the outbreak of Covid-19, the search for effective treatments and a vaccine to stem the spread of the pandemic has generated much political debate and many headlines. The race to find a vaccine has been particularly fierce among big pharmaceutical companies competing to become the first to commercialise it on the market. According to the New York Times, more than 135 vaccines are being developed, with two reaching the phase of large-scale efficacy tests—the final stage before deployment.

These companies are prime recipients of billions of euro in public money to support research and development to find a vaccine. The European Commission, through its Coronavirus Global Response, has raised €7.4 billion towards this end.

A major motivation for many of these efforts is the desire to find a cure for the pandemic that has infected millions of people around the world, killed hundreds of thousands, and disproportionately affected the most vulnerable. This however is only part of the picture.

First-mover advantage

Big pharmaceutical corporates are aggressively seeking what in the business world is known as ‘first-mover advantage’. The risk is that the first to develop an effective Covid-19 vaccine files for a patent which could make it sole supplier. Shareholders are pouring billions into these companies, in the hope of reaping big dividends.

Such exclusivity usually applies for 20 years but companies are known to manipulate the system to secure extensions. They can make minor changes, including to the colour of a pill, to renew a patent—changes which may not have benefits for patients but are sufficient to extend control over the drug and who can thus have access to it.

Join our growing community newsletter!

"Social Europe publishes thought-provoking articles on the big political and economic issues of our time analysed from a European viewpoint. Indispensable reading!"

Polly Toynbee

Columnist for The Guardian

Thank you very much for your interest! Now please check your email to confirm your subscription.

There was an error submitting your subscription. Please try again.

Powered by ConvertKit

Crucially, patents allow businesses to set prices—extremely high prices for first-mover pharmaceutical companies able to exploit the absence of alternatives in the market. This artificial inflation drives up costs for our public healthcare systems and increases the proportion of public money going to multinational companies, many based abroad, turning access to lifesaving drugs from a universal right into a privilege. Private health has already flourished in some European Union countries at the behest of the ‘troika’ (of the commission, the European Central Bank and the International Monetary Fund) supervising bailout programmes.

The current arrangements mean that those who are able to pay for drugs will obtain privileged access to a Covid-19 vaccine. Those unable to pay will be left stranded. We have seen how this story ends. An unjust and unequal system will mean millions of lost lives.

Universal access

But it needn’t be this way. Alternatives exist. Putting the public good above private interests means respecting the right to cure in public healthcare systems with universal access.

I am greatly inspired by the actions of the freedom-fighter, and South Africa’s first democratically-elected president, Nelson Mandela, who in the 1990s challenged the international patents system and the predatory behaviour of pharmaceutical companies. Mandela accused big companies of exploitation by charging exorbitant prices for HIV-AIDS drugs. He and his successor circumvented international patent rules to allow manufacturers to copy expensive drugs, delivering lower costs and saving lives.


We need your help! Please join our mission to improve public policy debates.


As you may know, Social Europe is an independent publisher. We aren't backed by a large publishing house or big advertising partners. For the longevity of Social Europe we depend on our loyal readers - we depend on you. You can support us by becoming a Social Europe member for less than 5 Euro per month.

Thank you very much for your support!

Become a Social Europe Member

Multinational corporations, backed by the US government, took the South African government to court, with Mandela as first defendant. Following international uproar, supported by a vibrant grassroots campaign, the drug companies however dropped the case, marking a huge victory for the right to cure.

Guarantees needed

The European Commission president, Ursula von der Leyen, has said that a Covid-19 vaccine would be universally accessible. But she has given no assurances as to how that would happen.

We need guarantees. The current system is broken. We cannot afford to lose more lives because of some companies’ desire to treat our health as a profitable commodity.

A progressive alliance across Europe, in which I take part, has launched a campaign to demand, first, that the EU condition research grants to pharmaceutical companies on universal access and, secondly, that the discriminatory and unjust patenting system be reformed, drawing on alternatives such as a universal patent pool.

A Covid-19 vaccine must be a public good. We have a right to cure.

Share on TwitterShare on FacebookShare on LinkedIn
Home ・ Challenging patents key to make Covid-19 vaccine work for all

Filed Under: Politics Tagged With: coronavirus

About Kateřina Konečná

Kateřina Konečná (KSČM, Czechia) is an MEP with the Left group in the European Parliament (GUE/NGL).

Partner Ads

Most Popular Posts

Thomas Piketty,capital Capital and ideology: interview with Thomas Piketty Thomas Piketty
sovereignty Brexit and the misunderstanding of sovereignty Peter Verovšek
China,cold war The first global event in the history of humankind Branko Milanovic
centre-left, Democratic Party The Biden victory and the future of the centre-left EJ Dionne Jr
Covid 19 vaccine Designing vaccines for people, not profits Mariana Mazzucato, Henry Lishi Li and Els Torreele

Most Recent Posts

socio-ecological contract The four ‘I’s of a new socio-ecological contract Philippe Pochet
SDR,special drawing rights Europe could make good use of a new SDR allocation Jayati Ghosh
supply chain,Germany,human rights Germany’s proposed supply-chain law—a glass half-empty Johanna Kusch and Claudia Saller
Myanmar,due diligence Human-rights due diligence and Myanmar Frank Hoffer
Uber,drivers,gig UK gig drivers recognised as workers—what next? Jill Toh

Other Social Europe Publications

RE No. 12: Why No Economic Democracy in Sweden?
US election 2020
Corporate taxation in a globalised era
The transformation of work
The coronavirus crisis and the welfare state

Foundation for European Progressive Studies Advertisement

FEPS Progressive Yearbook

Twenty-twenty has been an extraordinary year. The Covid-19 pandemic and the multidimensional crisis that it triggered have boosted existing trends and put forward new challenges. But they have also created unexpected opportunities to set a new course of action for the European Union and—hopefully—make a remarkable leap forward in European integration.

The second edition of the Progressive Yearbook, the yearly publication of the Foundation for European Progressive studies, revolves around the exceptional events of 2020 and looks at the social, economic and political impact they will have in 2021. It is a unique publication, which aims to be an instrument for the progressive family to reflect on the recent past and look ahead to our next future.


CLICK HERE

Social Europe Publishing book

With a pandemic raging, for those countries most affected by Brexit the end of the transition could not come at a worse time. Yet, might the UK's withdrawal be a blessing in disguise? With its biggest veto player gone, might the European Pillar of Social Rights take centre stage? This book brings together leading experts in European politics and policy to examine social citizenship rights across the European continent in the wake of Brexit. Will member states see an enhanced social Europe or a race to the bottom?

'This book correctly emphasises the need to place the future of social rights in Europe front and centre in the post-Brexit debate, to move on from the economistic bias that has obscured our vision of a progressive social Europe.' Michael D Higgins, president of Ireland


MORE INFO

Hans Böckler Stiftung Advertisement

Renewing labour relations in the German meat industry: an end to 'organised irresponsibility'?

Over the course of 2020, repeated outbreaks of Covid-19 in a number of large German meat-processing plants led to renewed public concern about the longstanding labour abuses in this industry. New legislation providing for enhanced inspection on health and safety, together with a ban on contract work and limitations on the use of temporary agency employees, holds out the prospect of a profound change in employment practices and labour relations in the meat industry. Changes in the law are not sufficient, on their own, to ensure decent working conditions, however. There is also a need to re-establish the previously high level of collective-bargaining coverage in the industry, underpinned by an industry-wide collective agreement extended by law to cover the entire sector.


FREE DOWNLOAD

ETUI advertisement

ETUI/ETUC (online) conference Towards a new socio-ecological contract 3-5 February 2021

The need to effectively tackle global warming puts under pressure the existing industrial relations models in Europe. A viable world of labour requires a new sustainability paradigm: economic, social and environmental.

The required paradigm shift implies large-scale economic and societal change and serious deliberation. All workers need to be actively involved and nobody should be left behind. Massive societal coalitions will have to be built for a shared vision to emerge and for a just transition, with fairly distributed costs, to be supported. But this is also an opportunity to redefine our societal goals and how they relate to the current focus on (green) growth.


REPLAY ALL SESSIONS

To access the videos, click on the chosen day then click on the ‘video’ button of your chosen session (plenary or panel). It will bring you immediately to the corresponding video. To access the available presentations, click on the chosen day then click on the ‘information’ button. Check the links to the available presentations.

Eurofound advertisement

Industrial relations: developments 2015-2019

Eurofound has monitored and analysed developments in industrial relations systems at EU level and in EU member states for over 40 years. This new flagship report provides an overview of developments in industrial relations and social dialogue in the years immediately prior to the Covid-19 outbreak. Findings are placed in the context of the key developments in EU policy affecting employment, working conditions and social policy, and linked to the work done by social partners—as well as public authorities—at European and national levels.


CLICK FOR MORE INFO

About Social Europe

Our Mission

Article Submission

Legal Disclosure

Privacy Policy

Copyright

Social Europe ISSN 2628-7641

Find Social Europe Content

Search Social Europe

Project Archive

Politics Archive

Economy Archive

Society Archive

Ecology Archive

.EU Web Awards